All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a healthcare professional.

The PsOPsA Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

Improving outcomes for people of color with chronic plaque psoriasis including scalp involvement

with Paolo Gisondi, Andrew Alexis, and Mona Shahriari

Thursday, February 6, 2025
16:00-17:00 GMT

Register now

This independent educational activity is supported by an educational grant from Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC. All content is developed independently by the faculty. The funder is allowed no influence on the content.

  TRANSLATE

The PsOPsA Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the PsOPsA Hub cannot guarantee the accuracy of translated content. The PsOPsA Hub and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.

Steering CommitteeAbout UsNewsletterContact
LOG IN
You're logged in! Click here any time to manage your account or log out.
LOG IN
You're logged in! Click here any time to manage your account or log out.

The PsOPsA Hub is supported by educational grants. All educational content is developed independently by SES in collaboration with our expert steering committee, with no input or influence from financial supporters. We would like to express our gratitude to the following companies for their support: • UCB: For website development, launch, and ongoing maintenance. • UCB and Bristol Myers Squibb: For educational content and news updates.

2023-05-15T15:05:51.000Z

What is teledermatology and does it have a place in the management of psoriasis?

May 15, 2023
Share:
Learning objective: After reading this article, learners will be able to cite a new development in psoriasis.

The Psoriasis and Psoriatic Arthritis Hub was pleased to speak with Peter van de Kerkhof, Radboud University, Nijmegen, NL. We asked, What is teledermatology and does it have a place in the management of psoriasis?

What is teledermatology and does it have a place in the management of psoriasis?

In this interview, van de Kerkhof outlines the drivers for the development of telemedicine during the COVID-19 pandemic and provides context for why this was vital to facilitate treatment when face-to-face consultations were difficult. Van de Kerkhof weighs the benefits and drawbacks of the use of photos and video conferencing, with a focus on privacy, and equipment and internet accessibility as barriers. Van de Kerkhof also looks at where telemedicine can be successfully implemented, noting scenarios where face-to-face consultation is still required to effectively treat a patient. This interview concludes with a look at the future applications of telemedicine, considering its use in conjunction with typical consultations and the patient experience.

More about...

Your opinion matters

HCPs, what is your preferred format for educational content on the PsOPsA Hub?
13 votes - 19 days left ...

Newsletter

Subscribe to get the best content related to Psoriasis and Psoriatic Arthritis delivered to your inbox